Natco Pharma announced that the US Food and Drug Administration has granted tentative approval to its Abbreviated New Drug Application ANDA for Trabectedin for Injection generic for Yondelis for the 1mgvial presentation According to industry sales data Yondelis generated annual sales of $497 million for the twelve months ending June 2022 in the US market
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.